Since the expression of SUV39H2 is restricted in testis in adult tissues and is significantly elevated in various cancer types such as non-small cell lung cancer, bladder cancer and prostate cancer [23], SUV39H2 appears to be an ideal target for development of anti-cancer treatment. The gene discussed is SUV39H2; the disease is urinary bladder carcinoma.